Global Onychomycosis Treatment Market

Onychomycosis Treatment Market Size, Share, Growth Analysis, By Treatment Type (Drugs, Lasers), By Disease Indication (Distal Subungual Onychomycosis, White Superficial Onychomycosis), By Age Group (18 to 39 Years, 40 to 64 Years), By Gender (Male, Female), By Distribution Channel (Institutional Sales, Retail Sales), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35H2265 | Region: Global | Published Date: November, 2024
Pages: 208 | Tables: 119 | Figures: 69

Onychomycosis Treatment Market Competitive Landscape

The global Onychomycosis Treatment market is a highly competitive global market driven by a large number of international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment.

Top Player’s Company Profiles

  • Teva Pharmaceutical Industries Ltd. (Israel)  
  • Sanofi S.A. (France)  
  • Medimetriks Pharmaceuticals, Inc. (US)  
  • Galderma (Switzerland)  
  • Johnson & Johnson (US)  
  • Novartis AG (Switzerland)  
  • Moberg Pharma AB (Sweden)  
  • Cardinal Health, Inc. (US)  
  • Pfizer Inc. (US)  
  • Almirall, S.A. (Spain)  
  • Bayer AG (Germany)  
  • Viatris Inc. (US)  
  • GlaxoSmithKline plc (UK)  
  • Cipla Ltd. (India)  
  • Dr. Reddy’s Laboratories Ltd. (India)  
  • Evofem Biosciences, Inc. (US)  
  • Nabriva Therapeutics plc (Ireland)  
  • Kaken Pharmaceutical Co., Ltd. (Japan)  
  • Hikma Pharmaceuticals PLC (UK)  
  • Dermavant Sciences, Inc. (US)  
  • Sientra, Inc. (US)  
  • Zynerba Pharmaceuticals, Inc. (US)
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Onychomycosis Treatment Market size was valued at USD 4.52 billion in 2022 and is poised to grow from USD 4.91 billion in 2023 to USD 9.5 billion by 2031, growing at a CAGR of 8.60% during the forecast period (2024-2031).

The global Onychomycosis Treatment market is a highly competitive global market driven by a large number of international competitors. Prominent corporations with cutting-edge AI and ML technology are Google, IBM, Microsoft, and NVIDIA. To support a wide range of applications across industries, these industry experts concentrate on creating cutting-edge algorithms, scalable platforms, and reliable infrastructure. Rapid advances in technology, strategic alliances, and large expenditures on research and development define the competitive environment. 'Teva Pharmaceutical Industries Ltd. (Israel)  ', 'Sanofi S.A. (France)  ', 'Medimetriks Pharmaceuticals, Inc. (US)  ', 'Galderma (Switzerland)  ', 'Johnson & Johnson (US)  ', 'Novartis AG (Switzerland)  ', 'Moberg Pharma AB (Sweden)  ', 'Cardinal Health, Inc. (US)  ', 'Pfizer Inc. (US)  ', 'Almirall, S.A. (Spain)  ', 'Bayer AG (Germany)  ', 'Viatris Inc. (US)  ', 'GlaxoSmithKline plc (UK)  ', 'Cipla Ltd. (India)  ', 'Dr. Reddy’s Laboratories Ltd. (India)  ', 'Evofem Biosciences, Inc. (US)  ', 'Nabriva Therapeutics plc (Ireland)  ', 'Kaken Pharmaceutical Co., Ltd. (Japan)  ', 'Hikma Pharmaceuticals PLC (UK)  ', 'Dermavant Sciences, Inc. (US)  ', 'Sientra, Inc. (US)  ', 'Zynerba Pharmaceuticals, Inc. (US)'

The growing cases of fungal nail infection because of the aging population, growing diabetes cases, and growing rate of conditions that lower the immune system is fueling the growth of the onychomycosis treatment market. Moreover, the growing awareness of the condition among patients and regarding the diagnosis and advanced treatments among healthcare professionals is resulting in an increasing number of diagnoses.

Blue Light and Carbon Dioxide Lasers: Carbon Dioxide lasers and Blue Light are adopted to cure toenail fungus, with CO2 lasers leading in adoption. These lasers can penetrate deep areas in the nail and reach the infection effectively. The blue light lasers are used for mild cases or in conjunction with different treatments, both approaches work by offering heat energy to demolish the fungus.

Geographically, North America is the dominating region among others and is expected to lead over the forecast period owing to the growing cases of onychomycosis due to many factors like growing prevalence of diabetes, ageing population, and lifestyle changes, especially in the leading nations like Canada and the United States. The growing awareness among the patients and the medical professionals regarding fungal infections of nail is notably contributing to the increased diagnosis and the number of treatment rates. The region is also benefitted by the high-tech healthcare infrastructure, comprising easy access to many treatment options and advanced diagnostic technologies. The key players operating in the region include Bausch Health Companies Inc., Pfizer Inc., Johnson & Johnson Services, Inc. and more.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Onychomycosis Treatment Market

Report ID: SQMIG35H2265

$5,300
BUY NOW GET FREE SAMPLE